Rohit Bose

3.4k total citations · 2 hit papers
27 papers, 2.1k citations indexed

About

Rohit Bose is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Rohit Bose has authored 27 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 11 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Rohit Bose's work include Prostate Cancer Treatment and Research (11 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Rohit Bose is often cited by papers focused on Prostate Cancer Treatment and Research (11 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Rohit Bose collaborates with scholars based in United States and Canada. Rohit Bose's co-authors include Jeffrey L. Wrana, Barish Ozdamar, Miriam Barrios‐Rodiles, Hongrui Wang, Yue Zhang, Valbona Luga, Yoshihide Hayashizaki, Ian W. Taylor, Fukiko Shinjo and Joanna Dembowy and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Rohit Bose

24 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regulation of the Polarity Protein Par6 by TGFß Receptors Controls Epithelial Cell Plasticity

2005 693 citations Barish Ozdamar, Rohit Bose et al. Science profile →
High-Throughput Mapping of a Dynamic Signaling Network in Mammalian Cells

2005 553 citations Miriam Barrios‐Rodiles, Kevin R. Brown et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rohit Bose United States	12	1.7k	523	485	282	280	27	2.1k
Barish Ozdamar Canada	9	1.7k 1.0×	482 0.9×	556 1.1×	100 0.4×	205 0.7×	9	2.1k
David R. Croucher Australia	24	1.3k 0.8×	507 1.0×	338 0.7×	145 0.5×	486 1.7×	47	2.1k
Peter J. Coopman France	23	1.5k 0.9×	460 0.9×	613 1.3×	173 0.6×	448 1.6×	51	2.3k
Yaara Zwang Israel	17	1.5k 0.9×	645 1.2×	709 1.5×	158 0.6×	282 1.0×	19	2.1k
Karl Dykema United States	25	1.3k 0.8×	465 0.9×	179 0.4×	478 1.7×	543 1.9×	41	2.0k
Stéphane Dedieu France	28	1.1k 0.7×	339 0.6×	459 0.9×	134 0.5×	577 2.1×	63	2.1k
Thomas Kitzing Germany	16	1.2k 0.7×	584 1.1×	613 1.3×	137 0.5×	358 1.3×	22	1.9k
Christopher G. Hubert United States	18	1.1k 0.6×	612 1.2×	163 0.3×	201 0.7×	510 1.8×	30	2.0k
Matthew Holderfield United States	17	1.7k 1.0×	564 1.1×	281 0.6×	147 0.5×	266 0.9×	25	2.2k

Countries citing papers authored by Rohit Bose

Since Specialization

Citations

This map shows the geographic impact of Rohit Bose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rohit Bose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rohit Bose more than expected).

Fields of papers citing papers by Rohit Bose

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rohit Bose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rohit Bose. The network helps show where Rohit Bose may publish in the future.

Co-authorship network of co-authors of Rohit Bose

This figure shows the co-authorship network connecting the top 25 collaborators of Rohit Bose. A scholar is included among the top collaborators of Rohit Bose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rohit Bose. Rohit Bose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Johns, Christopher, Hala T. Borno, Samuel L. Washington, et al.. (2025). Development of a culturally tailored educational tool designed to increase access to somatic testing among Black men with metastatic prostate cancer (mPCa).. Journal of Clinical Oncology. 43(16_suppl). 1591–1591.

Kwon, Daniel H., Hala T. Borno, Rohit Bose, et al.. (2024). Patients Can Administer Mobile Audio Recordings to Increase Knowledge in Advanced Prostate Cancer. Cancer Medicine. 13(22). e70433–e70433.

Zhu, Xiaolin, Li Zhang, Kevin Reyes, et al.. (2023). Association of biomarkers and response to immune checkpoint inhibitors (ICIs) in patients with metastatic urothelial carcinoma (mUC) with high and low tumor mutation burden (TMB).. Journal of Clinical Oncology. 41(6_suppl). 534–534. 2 indexed citations

Reyes, Kevin, Li Zhang, Xiaolin Zhu, et al.. (2023). Association of biomarkers and outcomes in patients (pts) with metastatic urothelial carcinoma (mUC) treated with immune checkpoint inhibitors (ICIs).. Journal of Clinical Oncology. 41(6_suppl). 532–532. 3 indexed citations

Ogura, Koichi, Arielle Elkrief, Anita S. Bowman, et al.. (2022). Prospective Clinical Genomic Profiling of Ewing Sarcoma: ERF and FGFR1 Mutations as Recurrent Secondary Alterations of Potential Biologic and Therapeutic Relevance. JCO Precision Oncology. 6(6). e2200048–e2200048. 6 indexed citations

Aggarwal, Rahul, Ivan de Kouchkovsky, Eric J. Small, et al.. (2022). 1379P A phase Ib study of a single priming dose of 177Lu-PSMA-617 coupled with pembrolizumab in metastatic castration resistant prostate cancer (mCRPC). Annals of Oncology. 33. S1173–S1173. 2 indexed citations

Kwon, Daniel H., Julian C. Hong, Osama Mohamad, et al.. (2022). Serial stereotactic body radiation therapy for oligometastatic prostate cancer detected by novel PET-based radiotracers. Urologic Oncology Seminars and Original Investigations. 41(3). 145.e7–145.e15. 2 indexed citations

Kouchkovsky, Ivan de, Dohee Kwon, Hala T. Borno, et al.. (2022). 1404P A phase II study of ZEN-3694 (ZEN), enzalutamide (ENZ), and pembrolizumab (P) in metastatic castration resistant prostate cancer (mCRPC): Interim safety results. Annals of Oncology. 33. S1187–S1187. 3 indexed citations

Ryan, Matthew J. & Rohit Bose. (2019). Genomic Alteration Burden in Advanced Prostate Cancer and Therapeutic Implications. Frontiers in Oncology. 9. 1287–1287. 24 indexed citations

10.

Adams, Elizabeth, Wouter R. Karthaus, Elizabeth Hoover, et al.. (2019). FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes. Nature. 571(7765). 408–412. 168 indexed citations

11.

Kelly, William Kevin, James Luke Godwin, Jean Hoffman‐Censits, et al.. (2018). c15-153: Randomized phase IB/II study of enzalutamide with and without ribociclib in patients with metastatic castrate resistant, chemotherapy naïve prostate cancer that retains RB expression.. Journal of Clinical Oncology. 36(6_suppl). TPS384–TPS384. 1 indexed citations

12.

Bose, Rohit, Wouter R. Karthaus, Joshua Armenia, et al.. (2017). ERF mutations reveal a balance of ETS factors controlling prostate oncogenesis. Nature. 546(7660). 671–675. 57 indexed citations

13.

Narimatsu, Masahiro, Rohit Bose, Melanie Pye, et al.. (2009). Regulation of Planar Cell Polarity by Smurf Ubiquitin Ligases. Cell. 137(2). 295–307. 268 indexed citations

14.

Viloria‐Petit, Alicia, Laurent David, Jun Jia, et al.. (2009). A role for the TGFβ-Par6 polarity pathway in breast cancer progression. Proceedings of the National Academy of Sciences. 106(33). 14028–14033. 104 indexed citations

15.

Bose, Rohit & Jeffrey L. Wrana. (2006). Regulation of Par6 by extracellular signals. Current Opinion in Cell Biology. 18(2). 206–212. 56 indexed citations

16.

Wang, Hongrui, Abiodun A. Ogunjimi, Yue Zhang, et al.. (2006). Degradation of RhoA by Smurf1 Ubiquitin Ligase. Methods in enzymology on CD-ROM/Methods in enzymology. 406. 437–447. 64 indexed citations

17.

Barrios‐Rodiles, Miriam, Kevin R. Brown, Barish Ozdamar, et al.. (2005). High-Throughput Mapping of a Dynamic Signaling Network in Mammalian Cells. Science. 307(5715). 1621–1625. 553 indexed citations breakdown →

18.

Ozdamar, Barish, Rohit Bose, Miriam Barrios‐Rodiles, et al.. (2005). Regulation of the Polarity Protein Par6 by TGFß Receptors Controls Epithelial Cell Plasticity. Science. 307(5715). 1603–1609. 693 indexed citations breakdown →

19.

Bose, Rohit, et al.. (1999). Spectroscopic characterization by laser flash photolysis of electrophilic intermediates derived from 4-aminostilbenes. Stilbene “nitrenium” ions and quinone methide imines †. Journal of the Chemical Society Perkin Transactions 2. 1591–1600. 15 indexed citations

20.

Como, Charles J. Di, Rohit Bose, & Kim Arndt. (1995). Overexpression of SIS2, which contains an extremely acidic region, increases the expression of SWI4, CLN1 and CLN2 in sit4 mutants.. Genetics. 139(1). 95–107. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact